The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets• Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination•

Category: Clinical & Manufacturing

Synlogic Reports Positive Top-line Data from Phase 1/2a Study of SYNB1618 in Patients with PKU
Clinical & Manufacturing

Synlogic Reports Positive Top-line Data from Phase 1/2a Study of SYNB1618 in Patients with PKU

JUL 16, 2019
4D pharma plc Commences Phase I/II Asthma Trial
Clinical & Manufacturing

4D pharma plc Commences Phase I/II Asthma Trial

JUL 8, 2019
Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose Intolerance
Clinical & Manufacturing

Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose Intolerance

JUL 6, 2019
OxThera Initiates Extension Part of a Phase 3 Study of Oxabact in Primary Hyperoxaluria
Clinical & Manufacturing

OxThera Initiates Extension Part of a Phase 3 Study of Oxabact in Primary Hyperoxaluria

JUN 20, 2019
4D Pharma Clinical Update on MRx0518 Oncology Programmes
Clinical & Manufacturing

4D Pharma Clinical Update on MRx0518 Oncology Programmes

MAY 1, 2019
MaaT Pharma Announces Second Positive DSMB Safety Assessment of Phase II HERACLES Study in Acute GvHD
Clinical & Manufacturing

MaaT Pharma Announces Second Positive DSMB Safety Assessment of Phase II HERACLES Study in Acute GvHD

APR 11, 2019
The Human Microbiome: A Diversity of Players Ranging from Academics to Dedicated Platforms
Clinical & Manufacturing

The Human Microbiome: A Diversity of Players Ranging from Academics to Dedicated Platforms

APR 3, 2019
New Randomized Double-Blind Placebo-Controlled Trial Finds Probiotics to Benefit Mood and Quality of Sleep in Healthy Students
Biotics and Supplements

New Randomized Double-Blind Placebo-Controlled Trial Finds Probiotics to Benefit Mood and Quality of Sleep in Healthy Students

APR 1, 2019
Clinical Study Results Demonstrate Benefits of High-Potency, Multi-Strain Probiotic Formulations
Biotics and Supplements

Clinical Study Results Demonstrate Benefits of High-Potency, Multi-Strain Probiotic Formulations

MAR 25, 2019
SNIPR BIOME raises $50 million Series A financing to advance CRISPR-based microbiome drugs to human clinical trials
Clinical & Manufacturing

SNIPR BIOME raises $50 million Series A financing to advance CRISPR-based microbiome drugs to human clinical trials

MAR 11, 2019
Acurx Announces First-In-Man Clinical Trial Data of ACX-362E for CDI
Clinical & Manufacturing

Acurx Announces First-In-Man Clinical Trial Data of ACX-362E for CDI

FEB 28, 2019